PVRIG

PVRIG

PVRIG Molekülinformation

Molecule Name
Transmembrane protein PVRIG
Molekülalias
C7orf15,C7orf15MGC138295,CD112R,MGC104322,MGC138297,MGC2463,PVRIG,CD112 receptor
Drug Development Progress
Anzahl der klinischen Arzneimittel7
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
PVRIG,PVR Related Immunoglobulin Domain Containing,CD112 Receptor,Poliovirus Receptor-Related Immunoglobulin Domain-Containing Protein,Poliovirus Receptor Related Immunoglobulin Domain Containing,Nectin-2 Receptor,C7orf15,CD112R,Transmembrane Protein PVRIG,MGC2463
Molekülhintergrund
Human PVRIG (poliovirus receptor related immunoglobulin domain-containing protein), also known as CD112 receptor (CD112R), is an approximately 34 kDa single transmembrane protein in the poliovirus receptor-like protein (PVR) family. The CD112R gene encodes a putative single transmembrane protein, which is composed of a single extracellular IgV domain, one transmembrane domain, and a long intracellular domain. Notably, the intracellular domain of phatases. The extracellular domain sequence of human and mouse CD112R have 65.3% similarity. CD112R may act as a coinhibitory receptor that suppresses T-cell receptor-mediated signals.

PVRIG Produktliste

Species
  • Human(5)
  • Mouse(4)
  • Cynomolgus(2)
Tag
  • His Tag(4)
  • Fc Tag(3)
  • His Tag & Avi Tag(2)
  • Fc Tag & Avi Tag(1)
  • Mouse IgG Fc Tag(1)
Host
  • HEK293(11)
Conjugate
  • Unconjugated(8)
  • Biotin-labeled(3)
Grade
  • RUO(11)
Low Endotoxin
  • Yes(2)
  • No(9)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
PVRIG
Human PVRIG Protein, Mouse IgG2a Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISABLI

$360.00

100ug
PVRIG
Human PVRIG Protein, Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
HOTAvitag
PVG-H82E3
Biotinylated Human PVRIG Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
PVRIG
Human PVRIG Protein, His Tag
Human
HEK293
SDS-PAGE
ELISABLI

$360.00

100ug
PVRIG
Cynomolgus PVRIG Protein, Fc Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISABLI

$390.00

100ug
PVRIG
Cynomolgus PVRIG Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
Human PVRIG Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
PVRIG
Mouse PVRIG Protein, Fc Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$390.00

100ug
PVRIG
Mouse PVRIG Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$390.00

100ug
PVRIG
Avitag
PVG-M82E3
Biotinylated Mouse PVRIG Protein, His,Avitag™
Mouse
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-10 Of 11 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Antikörperprojekt-Handelsplattform

ProjektnameProjektphaseMolekültypMolekülquelleKrankheitsgebietIndikationen
TIGIT&PVRIG BsAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
Projektphase
PCC
Molekültyp
Monoclonal
Molekülquelle
Humanized Mouse
Krankheitsgebiet
Solid Tumor
Indikationen
Solid tumor
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
COM-701COM-701Phase 2 ClinicalCompugen Ltd
Breast Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
PM-1009PM1009Phase 2 Clinical
Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours
Details
SIM-0348SIM-0348Phase 1 ClinicalSimcere Pharmaceutical Group Ltd
Neoplasms; Solid tumours
Details
GSK-4381562SRF-813; GSK-4381562; GSK-4381562A; GSK4381562A; GSK’562Phase 1 ClinicalSurface Oncology Inc
Neoplasms; Solid tumours
Details
NM1FNM1F; TGI-2Phase 1 ClinicalHefei TG ImmunoPharma Co Ltd
Colorectal Neoplasms; Melanoma; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
SHR-2002SHR-2002Phase 1 ClinicalShanghai Hengrui Pharmaceutical Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd
Neoplasms
Details
JS-009JS009; TAB009; JS-009Phase 1 ClinicalShanghai Junshi Biosciences Co Ltd
Neoplasms; Solid tumours
Details
Customer Reviews